Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative...

Area of Science:

• Oncology
• Head and Neck Cancer Research
• Clinical Trial Design

Background:

• Locoregionally advanced p16+ oropharyngeal squamous cell carcinoma (OPSCC) patients do not benefit from treatment deintensification.
• Identifying optimal candidates for deintensification remains a challenge.

Purpose of the Study:

• Compare two methods for identifying patients eligible for treatment deintensification in p16+ OPSCC.
• Evaluate the utility of favorable risk criteria versus a predictive classifier (omega score).

Main Methods:

• Multi-institutional cohort study of 444 p16+ OPSCC patients.
• Compared NRG-HN005 eligibility criteria (favorable risk) with the Head and Neck Cancer Intergroup predictive classifier (omega score).
• Analyzed outcomes and systemic therapy allocation using Cox models and logistic regression.

Main Results:

• The omega score was a stronger predictor of receiving intensive therapy than favorable risk.
• Lower omega scores significantly decreased the relative hazard for cancer events.
• Simulations indicated that using omega scores improved the efficiency of hypothetical noninferiority trials.

Conclusions:

• The omega score is a valuable tool for selecting p16+ OPSCC patients for treatment deintensification.
• Incorporating relative cancer event risk refines patient selection for deintensification strategies.